Monday, December 2, 2024
Home 2024

Yearly Archives: 2024

2024 Watch List

We’re in Tampa for the Kentucky Derby.

Editor / Curator -
Institutional Analyst Newsletter

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX).

Editor / Curator -
2024 Watch List

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Editor / Curator -
2024 Watch List

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Launches Vaccine Manufacturing System.

Editor / Curator -
All News

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and...

Editor / Curator -
Mpox

Major Mpox Outbreak in the Democratic Republic of Congo.

Editor / Curator -
All News

Mpox Infections Rise to Almost Double Last Year’s Numbers.

Editor / Curator -
All News

Adding Asia Broadband (AABB) to Speculative Watch List.

Editor / Curator -
2024 Watch List

GeoVax to Present at World Vaccine Congress, Thursday April 4th.

Editor / Curator -
123...6Page 2 of 6

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.